Logo image of CRVO

CERVOMED INC (CRVO) Stock Analyst Earnings Estimates

NASDAQ:CRVO - Nasdaq - US15713L1098 - Common Stock

2.18  0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
CRVO revenue by date.CRVO revenue by date.
7.145M9.586M
34.17%
5.391M
-43.76%

-100.00%
1.7M27.403M
1,511.94%
77.544M
182.98%
656.38M
746.46%
1.235B
88.15%
EBITDA
YoY % growth
CRVO ebitda by date.CRVO ebitda by date.
-15.95M
-0.50%
-15.97M
-0.13%
N/A
8.03%
-18.562M
-26.38%
-25.836M
-39.19%
-44.372M
-71.74%
-60.18M
-35.63%
-59.16M
1.69%
-48.96M
17.24%
-219.3M
-347.92%
131.07M
159.77%
415.65M
217.12%
EBIT
YoY % growth
CRVO ebit by date.CRVO ebit by date.
-16.04M
-0.44%
-15.97M
0.44%
-7.013M
56.09%
-17.103M
-143.88%
-22.981M
-34.37%
-41.716M
-81.52%
-51.536M
-23.54%
-55.386M
-7.47%
-26.077M
52.92%
-97.677M
-274.57%
402.51M
512.08%
889.61M
121.02%
Operating Margin
CRVO operating margin by date.CRVO operating margin by date.
N/AN/A-98.15%-178.42%-426.29%N/AN/A-3,258.00%-95.16%-125.96%61.32%72.03%
EPS
YoY % growth
CRVO eps by date.CRVO eps by date.
-9.50
26.92%
N/A
14.86%
N/A
82.98%
-1.82
-32.27%
-1.45
20.16%
-2.23
-53.33%
-2.39
-7.04%
-1.39
41.88%
-0.52
62.87%
-1.51
-193.07%
6.98
562.16%
13.14
88.30%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.50
-30.86%
-0.60
-46.78%
-0.80
-194.67%
-0.82
-48.36%
-0.84
-68.21%
Revenue
Q2Q % growth
3.128M
25.59%
1.734M
-26.12%
1.734M
-47.28%
1.734M
-10.62%
1.734M
-44.57%
EBITDA
Q2Q % growth
-5.508M
-260.00%
-7.344M
-227.27%
-9.894M
-148.72%
-10.404M
-161.54%
-10.914M
-98.15%
EBIT
Q2Q % growth
-4.59M
-173.14%
-7.446M
-186.94%
-9.996M
-233.75%
-10.506M
-94.69%
-11.016M
-140.00%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.55
21.43%
-0.42-0.13-30.72%
Q2 2024
Q2Q % growth
-0.27
86.28%
-0.310.0413.49%
Q1 2024
Q2Q % growth
-0.41
78.95%
-0.40-0.01-3.07%
Q4 2023
Q2Q % growth
-0.38
83.07%
-0.30-0.08-28.47%
Q3 2023
Q2Q % growth
-0.70
65.94%
-0.970.2727.76%
Q2 2023
Q2Q % growth

36.29%
-1.97%
Q1 2023
Q2Q % growth

41.50%
-1.95%
Q4 2022
Q2Q % growth

25.20%
-2.24%
Q3 2022
Q2Q % growth
-2.06
-37.00%
-3.151.1034.80%
Q2 2022
Q2Q % growth
-3.09
-54.50%
-3.120.031.00%
Q1 2022
Q2Q % growth
-3.33
-11.00%
-2.68-0.65-24.37%
Q4 2021
Q2Q % growth
-3.00 -3.060.061.96%
Q3 2021
Q2Q % growth
-1.50
57.14%
-2.040.5426.47%
Q2 2021
Q2Q % growth
-2.00
33.33%
-2.300.2912.85%
Q1 2021
Q2Q % growth
-3.00
14.29%
-2.30-0.71-30.72%
Q4 2020
Q2Q % growth
-3.00
45.45%
-2.55-0.45-17.65%
Q3 2020
Q2Q % growth
-3.50
88.33%
-2.81-0.69-24.78%
Q2 2020
Q2Q % growth
-3.00
90.48%
-2.81-0.19-6.95%
Q1 2020
Q2Q % growth
-3.50
91.36%
-4.340.8419.26%
Q4 2019
Q2Q % growth
-5.50 -6.891.3820.12%
Q3 2019
Q2Q % growth
-30.00 -36.216.2117.15%
Q2 2019
Q2Q % growth
-31.50 -35.193.6910.49%
Q1 2019
Q2Q % growth
-40.50 -46.165.6612.25%
CRVO Yearly EPS VS EstimatesCRVO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 -200 -400 -600 -800 -1K
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
1.94M
27.13%
3.128M-1.188M-37.98%
Q2 2024
Q2Q % growth
3.289M
5.08%
2.244M1.045M46.57%
Q1 2024
Q2Q % growth
2.347M 1.377M970K70.44%
Q4 2023
Q2Q % growth
2.491M 2.04M450.58K22.09%
CRVO Yearly Revenue VS EstimatesCRVO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -1.56% 0% -9.33%
Revenue0% 53.33% 0% -13.19%